In this “Your Stories” podcast from Conquer Cancer, the ASCO Foundation, Dr. Judith Kaur and her husband, Alan Kaur, discuss how their commitment to each other as a married couple has translated into another partnership to advance cancer research.
In this podcast, Dr. Petros Grivas and Dr. Edith Mitchell discuss what health care disparities are, how they affect people with cancer, and why involvement of minority populations in cancer clinical trials is so important.
Dr. Neeraj Agarwal discusses 3 clinical trials presented at the 2020 ESMO Virtual Congress that studied new treatments for advanced kidney cancer, prostate cancer, and bladder cancer.
Heard about a new cancer treatment in the news? Learn how FDA-approved, off-label, and investigational drugs are made available to patients.
The 2020 National Cancer Opinion Survey reveals the COVID-19 pandemic’s effects on cancer screening and mental health, racism’s impact on health care, and widely held misperceptions about cancer clinical trials.
In the latest podcast from the “Clinical Trials in Genitourinary Cancers” series, experts discuss 3 clinical trials testing potential new treatments for prostate cancer, germ cell tumors, and kidney cancer.
In the latest podcast in the “Clinical Trials in Genitourinary Cancers” series, experts discuss 3 clinical trials testing potential new treatments for prostate, bladder, and kidney cancers.
In this Q&A, Dr. Enrique Soto discusses the benefits and potential challenges adults age 65 or older may experience when finding or participating in a cancer clinical trial.
After Cathy Jordan’s treatment for triple-negative breast cancer wasn’t effective, here’s what she considered before joining a clinical trial.
Read research highlights just released from the ASCO20 Virtual Scientific Program. They include studies on immunotherapy for metastatic colorectal cancer and gestational trophoblastic disease, maintenance therapy for advanced bladder cancer, the potential of precision medicine for childhood cancers, and targeted therapy after surgery for EGFR-positive non-small cell lung cancer.
